Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOLEUCOVORIN Cause Performance status decreased? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Performance status decreased have been filed in association with LEVOLEUCOVORIN (Levoleucovorin). This represents 0.2% of all adverse event reports for LEVOLEUCOVORIN.

5
Reports of Performance status decreased with LEVOLEUCOVORIN
0.2%
of all LEVOLEUCOVORIN reports
1
Deaths
4
Hospitalizations

How Dangerous Is Performance status decreased From LEVOLEUCOVORIN?

Of the 5 reports, 1 (20.0%) resulted in death, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Performance status decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOLEUCOVORIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOLEUCOVORIN Cause?

Diarrhoea (302) Nausea (274) Neutropenia (246) Decreased appetite (223) Neuropathy peripheral (178) Neutrophil count decreased (176) Pyrexia (175) Vomiting (167) Febrile neutropenia (130) Off label use (125)

What Other Drugs Cause Performance status decreased?

BACLOFEN (156) LENALIDOMIDE (118) PACLITAXEL (112) BEVACIZUMAB (103) SODIUM OXYBATE (103) CARBOPLATIN (100) DEXAMETHASONE (80) CAPECITABINE (75) NIRAPARIB (75) LUMATEPERONE (68)

Which LEVOLEUCOVORIN Alternatives Have Lower Performance status decreased Risk?

LEVOLEUCOVORIN vs LEVOMEPROMAZINE LEVOLEUCOVORIN vs LEVOMETHADONE LEVOLEUCOVORIN vs LEVOMILNACIPRAN LEVOLEUCOVORIN vs LEVONORGESTREL LEVOLEUCOVORIN vs LEVORPHANOL

Related Pages

LEVOLEUCOVORIN Full Profile All Performance status decreased Reports All Drugs Causing Performance status decreased LEVOLEUCOVORIN Demographics